CE: Febrile neutropenia in the chemotherapy patient Review
| Authors: | Foley, A. M.; Hoffman, M. |
| Review Title: | CE: Febrile neutropenia in the chemotherapy patient |
| Abstract: | ABSTRACT: Febrile neutropenia is a serious complication of chemotherapy treatment and may present as the only clinical sign of infection. If not addressed in a timely manner, it may progress to multisystem organ failure and may be fatal. Initial assessment of fever in those receiving chemotherapy requires prompt administration of antibiotics, ideally within one hour of presentation. Depending on the clinical status of the patient, antibiotic treatment may occur in the inpatient or outpatient setting. Nurses play an important role in the identification and treatment of patients at high risk for febrile neutropenia through assessment and adherence to clinical practice guidelines. In addition, nurses play an active role in patient education regarding risk factors, protective measures, and signs and symptoms of infection in the immunocompromised oncology patient. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved. |
| Keywords: | neoplasm; neoplasms; febrile neutropenia; fever; antiinfective agent; anti-bacterial agents; hospital patient; complication; inpatients; humans; human |
| Journal Title: | American Journal of Nursing |
| Volume: | 123 |
| Issue: | 5 |
| ISSN: | 0002-936X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2023-05-01 |
| Start Page: | 36 |
| End Page: | 42 |
| Language: | English |
| DOI: | 10.1097/01.NAJ.0000931888.96896.a1 |
| PUBMED: | 37021970 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 1 May 2023 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work